Treating H. pylori to improve metabolic syndrome
Part of Hormones & metabolism clinical trials.
This trial tests whether treating H. pylori infection can help improve metabolic syndrome (a group of conditions like high blood sugar, abnormal cholesterol, and high blood pressure). It aims to understand how treatment changes your gut bacteria and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been newly diagnosed with metabolic syndrome by your doctor.
- You have an active H. pylori infection confirmed by a breath test and have never been treated for it.
- You are not taking any medicines for blood sugar, cholesterol, or weight loss.
- You have not taken antibiotics or stomach-acid-reducing drugs recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.
This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
This trial tests a new combination of medicines to treat H. pylori infection that has not gone away after at least two previous treatments. It may help if you have not had success with standard therapy and are looking for another option.
This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.
This study looks at whether a common stomach infection (H. pylori) affects insulin resistance in people with metabolic syndrome. It uses simple tests like a breath test, stool sample, and blood draw to check if treating the infection could help improve metabolic health.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.